转铁蛋白偶联双氢青蒿素氧基苯甲酰肼的载药量分析

在含20%乙醇的B-R缓冲溶液(V/V,pH=7.2)中,利用电分析化学方法测得双氢青蒿素氧基苯甲酰肼(dihydroartemisininoxy benzoic acid hydrazide,DBAH)在银电极上于-0.66V(vs.SCE)处有一不可逆还原峰。DBAH与被高碘酸钠氧化后的转铁蛋白(holotransferrin,Tf)结合形成电活性复合物,其还原峰峰电位由-0.16V负移至-0.84V,峰电流随DBAH和Tf浓度的增加而增加。该法测得一个Tf分子可以与3个DBAH分子连接,其结合常数为5.1×1010。紫外可见吸收光谱法测定结果与电化学测定结果相吻合。实验结果表明,Tf与DBAH共价结合形成电活性复合物。     

阿糖胞苷金属卟啉衍生物的合成及光动力抗肿瘤活性

设计并合成了阿糖胞苷卟啉衍生物(AHP), 并通过金属插入反应获得了4种金属卟啉衍生物, 采用核磁共振、红外光谱、紫外-可见光谱和质谱等手段对化合物的结构进行了表征.光动力抗肿瘤活性实验结果表明, 含药浓度为25 μmol/L的ZnAHP经光照30 min后对人乳腺癌MCF-7细胞的光动力杀伤率平均达(45.86±8.20)%.     

基于AuNPs/PANI-NF复合膜的电化学细胞传感器对姜黄素诱导HeLa细胞凋亡的抑制作用检测

以聚苯胺纳米纤维(PANI-NF)-纳米金(AuNPs)复合膜构建传感界面,在AuNPs/PANI-NF界面上修饰转铁蛋白(Tf),利用转铁蛋白与人宫颈癌细胞(HeLa)表面大量表达的转铁蛋白受体(TfR)之间的特异性识别作用,将细胞捕获到传感器界面,导致电化学阻抗值变化。利用电化学阻抗谱研究姜黄素对HeLa细胞的抑制作用。结果表明,随着药物浓度的增大和作用时间的延长,电化学阻抗值下降,表明姜黄素对细胞的抑制作用增强。电化学阻抗值的变化率与药物浓度和作用时间具有量效关系;电化学方法检测显示,姜黄素对HeLa细胞的抑制作用趋势与MTT法及倒置显微镜检测到的姜黄素对HeLa细胞的抑制作用结果相吻合,从而建立了一种检测药物对细胞抑制作用的新方法。该方法具有简便、灵敏度高、费用低廉等优点。     

一种新型CO_2响应型肿瘤靶向药物传递载体

将透明质酸(HA)依次接枝1,12-二氨基十二烷和N,N-二甲基乙酰胺二甲缩醛(DADA),构建得到CO_2刺激响应的透明质酸-脒基(HA-ami)。为了考察其结构、CO_2刺激响应性、细胞水平作为药物载体的可行性和肿瘤靶向性,进行了结构表征、CO_2刺激响应性表征、细胞摄取、细胞毒性和体内的组织分布实验。结果表明:HA-ami成功构建,并具有一定的CO_2刺激响应性,可携带模型药物摄取进入人乳腺癌细胞(MCF-7),而且没有出现明显的细胞毒性,具有体内肿瘤靶向性。     

新型1,3-二取代酞嗪酮类衍生物的合成及抗肿瘤活性研究

为了寻找高效低毒的抗肿瘤药物,设计并合成新型的1,3位取代酞嗪酮类化合物.采用噻唑蓝(MTT)法对目标化合物在MCF-7(人乳腺癌细胞)、PC-3(人前列腺癌细胞)、SW-620(人结肠癌细胞)和HGC-27(人胃癌细胞)四种人类癌细胞的抗增殖活性进行评价.结果显示大部分化合物具有较好的抗增殖活性.其中,2-(4-(4-溴苯基)-1-氧代酞嗪-2(1H)-基)-N-(2-氟苯基)乙酰胺(5g)对MCF-7细胞的抗增殖活性较好,IC50值为6.01μmol/L,为抗肿瘤药物的研究提供了思路.     

冬凌草甲素卟啉壳聚糖微球的制备及体外光动力抗肿瘤活性研究

基于光-化联合抗肿瘤的目的,通过共价偶联将5-对(6-溴已氨基苯基)-10,15,20-三苯基卟啉(BHP)引入壳聚糖侧基制备复合物,卟啉枝接率平均达30.80%;采用乳化交联法制备了冬凌草甲素卟啉壳聚糖微球,经高效液相色谱(HPLC)测得微球载药量为12.41%,包封率为8.72%,48 h体外释放量达81.74%;采用噻唑蓝(MTT)法考察合成的系列化合物对人乳腺癌细胞MCF-7的光毒性.实验结果表明:浓度为25,50和100μmol/m L的冬凌草甲素光敏微球光照30min后对MCF-7细胞的光动力杀伤率的平均值分别达(31.55±1.70)%,(71.03±0.76)%和(82.74±0.38)%,光动力杀伤效果显著.     

靶向VEGFR受体抑制剂齐墩果酸衍生物的合成及初步抗肿瘤活性研究

以天然产物齐墩果酸为母体,设计合成齐墩果酸衍生物,采用计算机辅助药物设计,对C-3、C-28位结构改造,设计合成12个未见文献报道的靶向VEGFR受体抑制剂; 采用噻唑蓝(MTT)法,用人肝癌细胞(HepG2)和乳腺癌细胞(MCF-7)对其进行初步体外抗肿瘤活性筛选;其结构经1H-NMR、13C-NMR谱确证。活性测试得出化合物I7、II1与阳性对照药相比有较强抑制作用,其抗肿瘤活性高于母体OA,分子对接结果显示I7和II1 与 VEGFR 受体具有较好的结合能力,值得进一步研究。     

芳氨取代蒿苯醚的合成及抗乳腺癌活性研究

本文设计并合成14个以芳香氨基取代为特征的青蒿苯基醚类化合物,并在人乳腺癌MCF-7细胞及其耐药株MCF-7/Adr中测试该类化合物的生长抑制活性。筛选结果表明,DC06对MCF-7细胞和MCF-7/Adr细胞均抑制活性显著,GI_(50)分别为0. 10μm和0. 012μm。     

新型氨基酸甘油糖脂的合成及抗肿瘤活性

以甲基-α-D-吡喃葡萄糖、甘氨酸和缬氨酸为起始原料,设计合成了多种新型结构的氨基酸甘油糖脂衍生物(27~34),并对其结构进行了表征.采用四甲基偶氮唑蓝比色法(MTT法)研究了该类化合物对人乳腺癌细胞(MCF-7)、人肝癌细胞(Hcp G-2)和人白血病细胞(K562)的体外抑制活性.初步研究结果表明,在测试浓度范围内,化合物27(IC_(50)=3.53,4.71,4.13μmol/L),28(IC_(50)=4.35,4.57,5.79μmol/L),31(IC_(50)=3.91,3.73,4.54μmol/L)和32(IC_(50)=5.17,5.52,5.93μmol/L)对癌细胞具有较好的抑制作用,且对正常细胞无毒性.此类型糖脂可能成为很好的抗肿瘤药物原料化合物.     

新型青蒿砜-酯类衍生物的合成及其抗癌活性研究

以双氢青蒿素为起始原料,经胺化、氧化、烷基化、酯化反应,快速、高效地合成了一系列青蒿砜系列衍生物,目标化合物的结构通过IR、1H NMR、13C NMR和HRMS得到了确证;以四甲基偶氮唑盐比色法(MTT法),研究了该类化合物对人肝癌细胞株SMMC-7721的抗癌活性.初步研究结果表明,该类化合物具有明显地抑制人肝癌细胞增殖、诱导其凋亡的细胞活性,给药72 h,半数抑制浓度IC50最优值为0.06μmol/L.同时采用Annexin/PI流式细胞分析法检测化合物7b对人肝癌细胞SMMC-7721的凋亡情况,结果显示实验组与正常对照组相比人肝癌细胞早期凋亡率和总凋亡率均显著增加.在与青蒿素、双氢青蒿素(DHA)和青蒿砜的对比实验中发现,该类化合物的抗肿瘤活性明显提高,表现出了该类化合物在抗癌药物开发方面具有潜在的应用价值.     

Determination of the composition,encapsulation efficiency and loading capacity in protein drug delivery systems using circular dichroism spectroscopy

Peptides and proteins have become very promising drug candidates in recent decades due to their unique properties. However, the application of these drugs has been limited by their high enzymatic susceptibility, low membrane permeability and poor bioavailability when administered orally. Considerable efforts have been made to design and develop drug delivery systems that could transport peptides and proteins to targeted area. Although it is of great importance to determine the composition after loading a drug to the carrier, the ability to do so is significantly limited by current analytical methods. In this letter, five important proteins, α₁-antitrypsin, hemoglobin human, human serum albumin, human transferrin and r-globulin were chemically conjugated to two model drug carriers, namely carbon dots and polymer O-(2-carboxyethyl) polyethylene glycol. A simple yet convenient method based on circular dichroism spectroscopy was developed to determine the compositions of the various protein-carrier conjugates.     

荧光/MRI双模态靶向成像诊疗试剂的制备

在聚乙二醇二胺(NH_2-PEG-NH_2)修饰的石墨烯量子点(GODs)表面以酰胺键偶联二乙基三胺五乙酸(DTPA)分子,之后将Gd~(3+)离子与其进行配合,得到了GODs-Gd(DTPA)复合纳米粒子,然后再通过酰胺键在GODs-Gd(DTPA)的表面修饰叶酸(FA)靶分子,最后进一步将阿霉素(DOX)通过π-π堆垛吸附在造影剂的表面,制备了FA/GODs-Gd(DTPA)/DOX荧光/MRI双模态靶向肺癌细胞成像诊疗试剂,通过透射电子显微镜、紫外可见吸收光谱、荧光光谱和激光共聚焦扫描显微镜等手段表征了其形貌、发光性能和靶向成像性能。MRI、激光共聚焦扫描显微镜和MTT等结果表明,相对于正常的HLF细胞,所制备的FA/GODs-Gd(DTPA)/DOX纳米粒子能够靶向检测FA受体高表达的肺癌H460细胞,并具有明显的抗肿瘤活性。     

Dual‐Functional Nanographene Oxide as Cancer‐Targeted Drug‐Delivery System to Selectively Induce Cancer‐Cell Apoptosis

Construction of bioresponsive drug‐delivery nanosystems could enhance the anticancer efficacy of anticancer agents and reduce their toxic side effects. Herein, by using transferrin (Tf) as a surface decorator, we constructed a cancer‐targeted nanographene oxide (NGO) nanosystem for use in drug delivery. This nanosystem (Tf‐NGO@HPIP) drastically enhanced the cellular uptake, retention, and anticancer efficacy of loaded drugs but showed much lower toxicity to normal cells. The nanosystem was internalized through receptor‐mediated endocytosis and triggered pH‐dependent drug release in acidic environments and in the presence of cellular enzymes. Moreover, Tf‐NGO@HPIP effectively induced cancer‐cell apoptosis through activation of superoxide‐mediated p53 and MAPK pathways along with inactivation of ERK and AKT. Taken together, this study demonstrates a good strategy for the construction of bioresponsive NGO drug‐delivery nanosystems and their use as efficient anticancer drug carriers.     

Metallomics for drug development: Serum protein binding and analysis of an anticancer tris(8-quinolinolato)gallium(III) drug using inductively coupled plasma mass spectrometry

The application of an inductively coupled plasma mass spectrometry (ICP-MS) assay for quantifying in vitro binding of a gallium-based anticancer drug, tris(8-quinolinolato)gallium(III), to serum albumin and transferrin and in human serum is described. The distribution of the drug between the protein-rich and protein-free fractions was assessed via ICP-MS measurement of total gallium in ultrafiltrates. Comparative kinetic studies revealed that the drug exhibits a different reactivity toward individual proteins. While the maximum possible binding to albumin (~10%) occurs practically immediately, interaction with transferrin has a step-like character and the equilibrium state (with more than 50% binding) is reached for about 48 h. Drug transformation into the bound form in serum, also very fast, results in almost quantitative binding (~95%). The relative affinity of protein–drug binding was characterized in terms of the association constants ranging from 10³ to 10⁴ M⁻¹. In order to further promote clinical testing of the gallium drug, the ICP-MS method was applied for direct quantification of gallium in human serum spiked with the drug. The detection limit for gallium was found to be as low as 20 ng L^–1. The repeatability was better than 8% (as RSD) and the achieved recoveries were in the range 99–103%.     

Development and physicochemical characterization of doxorubicin-encapsulated hydroxyapatite–polyvinyl alcohol nanocomposite for repair of osteosarcoma-affected bone tissues

Nowadays locoregional therapy for cancer treatment can be associated with nanocomposite drug delivery systems. Coated nanoparticles have versatile applications for delivering chemotherapeutic drugs to the targeted part of the body. In this study, a ceramic carrier like nanosized hydroxyapatite (HAp) was synthesized by the in situ precipitation method followed by coating with anticancer drug like doxorubicin (DOX) and polyvinyl alcohol (PVA) polymer. The physicochemical characterization of the prepared polymer-coated drug ceramic nanocomposite (DOX-HAp-PVA) was carried out using Fourier transform infrared spectroscopy, X-ray diffraction, transmission electron spectroscopy, and particle size distribution. Furthermore, the biocompatibility and the anticancer activity of the nanocomposite were explored by MTT assay study. Successfully synthesized DOX-HAp-PVA nanocomposite exhibited a remarkable cytotoxicity toward osteosarcoma cells (MG 63), which may be potentially used as an anticancer agent against osteosarcoma.     

Facile construction of multivalent targeted drug delivery system from Boltorn® series hyperbranched aliphatic polyester and folic acid

The conjugation of PAMAM dendrimer and folic acid is a well‐studied multivalent targeted drug delivery system, but it is expensive and difficult to be synthesized. To construct an inexpensive and well‐defined multivalent targeted drug delivery system, a cheap carrier — Boltorn® series hyperbranched aliphatic polyester — was proposed as the nanodevice to carry fluorescein, folic acid, and methotrexate. The construction follows a facile route: (1) synthesizing the carrier — a hybrid hyperbranched polymer with acyclic hydroxyls and cyclic carbonate, (2) linking fluorescein to the hyperbranched polymer via the acyclic hydroxyls, (3) opening the ring of the cyclic carbonate with the amino group of folic acid, and (4) attaching the drug methotrexate to the resulting hydroxyls by ring‐opening reaction. In this route, the peripheral hydroxyls of the hyperbranched polymer are divided into two groups and reacted with three reagents in sequence to form the desired multivalent targeted drug delivery system. Copyright © 2009 John Wiley & Sons, Ltd.     

Synthesis of Imatinib‐loaded chitosan‐modified magnetic nanoparticles as an anti‐cancer agent for pH responsive targeted drug delivery

Targeted drug delivery is a promising approach to overcome the limitations of classical chemotherapy. In this respect, Imatinib‐loaded chitosan‐modified magnetic nanoparticles were prepared as a pH sensitive system for targeted delivery of drug to tumor sites by applying a magnetic field. The proposed magnetic nanoparticles were prepared through modification of magnetic Fe₃O₄ nanoparticles with chitosan and Imatinib. The structural, morphological and physicochemical properties of the synthesized nanoparticles were determined by different analytical techniques including energy‐dispersive X‐ray spectroscopy (EDS), field emission scanning electron microscopy (FESEM), Fourier‐transform infrared (FTIR) spectroscopy, high resolution transmission electron microscopy (HR‐TEM), vibrating sample magnetometry (VSM), X‐ray diffraction (XRD) and X‐ray photoelectron spectroscopy (XPS). UV/visible spectrophotometry was used to measure the Imatinib contents. Thermal stability of the prepared particles was investigated and their efficiency of drug loading and release profile were evaluated. The results demonstrated that Fe₃O₄@CS acts as a pH responsive nanocarrier in releasing the loaded Imatinib molecules. Furthermore, the Fe₃O₄@CS/Imatinib nanoparticles displayed cytotoxic effect against MCF‐7 breast cancer cells. Results of this study can provide new insights in the development of pH responsive targeted drug delivery systems to overcome the side effects of conventional chemotherapy.     

Mechanism of indium(III) exchange between NTA and transferrin: a kinetic approach

The equilibria and kinetics for the process of In(3+) exchange between nitrilotriacetic acid (NTA) and bovine serum transferrin (T) have been investigated in aqueous solution containing sodium bicarbonate. The metal exchange equilibria have been measured by difference ultraviolet spectroscopy at 25 degrees C, pH=7.4, and I=0.2 M (NaClO4). The acid dissociation constants of NTA and the binding constants of In(III) to NTA have also been measured. Kinetic experiments revealed that the process of In(3+) uptake by transferrin from [In(NTA)2](3-) is biphasic, the fast phase being completed in a few seconds, the slow phase lasting for hours. The fast phase has been investigated by the stopped-flow method and results in monoexponential kinetics. It involves rapid interaction of the 1:1 complex ML (M=In, L=NTA) with TB (T=transferrin, B=CO3(2-)) to give a quaternary intermediate MLTB which then evolves to an "open" MTB* ternary complex complex with expulsion of L. In turn, this complex interconverts to a "closed", more stable, form MTB. Neither the prevailing complex M2L nor the TB2 form of transferrin are directly involved in the exchange process but act as metal and protein reservoirs. The pH dependence of the reaction has been also investigated. The slow phase has not been investigated in detail; it takes several hours to go to the completeness, its slowness being ascribed to metal redistribution between the C-site and N-site of the protein, and/or metal release from polynuclear In(III) species.     

Solid-state NMR studies of pharmaceutical solids in polymer matrices

Biodegradable drug-delivery systems can be formulated to release drug for hours to years and have been used for the controlled release of medications in animals and humans. An important consideration in developing a drug-delivery matrix is knowledge of the long-term stability of the form of the drug and matrix after formulation and any changes that might occur to the drug throughout the delivery process. Solid-state NMR spectroscopy is an effective technique for studying the state of both the drug and the matrix. Two systems that have been studied using solid-state NMR spectroscopy are presented. The first system studied involved bupivacaine, a local anesthetic compound, which was incorporated into microspheres composed of tristearin and encapsulated using a solid protein matrix. Solid-state ¹³C NMR spectroscopy was used to investigate the solid forms of bupivacaine in their bulk form or as incorporated into the tristearin/protein matrix. Bupivacaine free base and bupivacaine-HCl have very different solid-state NMR spectra, indicating that the molecules of these compounds pack in different crystal forms. In the tristearin matrix, the drug form could be determined at levels as low as 1:100 (w/w), and the form of bupivacaine was identified upon loading into the tristearin/protein matrix. In the second case, the possibility of using solid-state ¹³C NMR spectroscopy to characterize biomolecules lyophilized within polymer matrices is evaluated by studying uniformly ¹³C-labeled asparagine (Asn) in 1:250 (w/w) formulations with poly(vinyl pyrrolidone) (PVP) and poly(vinyl alcohol) (PVA). This work shows the capability of solid-state NMR spectroscopy to study interactions between the amino acid and the polymer matrix for synthetic peptides and peptidomimetics containing selective ¹³C labeling at the Asn residue.